Guerbet S.A. (GBT)
Market Closed
4 Jul, 15:30
XPAR 
€
22. 50
+0.15
+0.67%
€
334.07M Market Cap
- P/E Ratio
0.5% Div Yield
19,271 Volume
0 Eps
€ 22.35
Previous Close Day Range
21.65 22.7
Year Range
17.42 40.25
Want to track GBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 79 days
Summary
GBT closed Friday higher at €22.5, an increase of 0.67% from Thursday's close, completing a monthly increase of 11.66% or €2.35. Over the past 12 months, GBT stock lost -15.73%.
GBT is not paying dividends to its shareholders.
The last earnings report, released on May 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Sep 24, 2025.
Guerbet S.A. has completed 1 stock splits, with the recent split occurring on Jan 23, 2014.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
GBT Chart
Loading, please wait...
Guerbet S.A. Dividends
| GBT 1 Jul 2024 | Other | €0.5 Per Share |
| GBT 29 Jun 2023 | Other | €0.5 Per Share |
| GBT 1 Jul 2022 | Other | €0.85 Per Share |
| GBT 29 Jun 2021 | Other | €0.7 Per Share |
| GBT 30 Jun 2020 | Other | €0.7 Per Share |
Guerbet S.A. Earnings
| 24 Sep 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 23 May 2025 Date | | - Cons. EPS | - EPS |
| 25 Sep 2024 Date | | - Cons. EPS | - EPS |
| 26 Jul 2024 Date | | - Cons. EPS | - EPS |
| 24 May 2024 Date | | - Cons. EPS | - EPS |
| GBT 1 Jul 2024 | Other | €0.5 Per Share |
| GBT 29 Jun 2023 | Other | €0.5 Per Share |
| GBT 1 Jul 2022 | Other | €0.85 Per Share |
| GBT 29 Jun 2021 | Other | €0.7 Per Share |
| GBT 30 Jun 2020 | Other | €0.7 Per Share |
| 24 Sep 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 23 May 2025 Date | | - Cons. EPS | - EPS |
| 25 Sep 2024 Date | | - Cons. EPS | - EPS |
| 26 Jul 2024 Date | | - Cons. EPS | - EPS |
| 24 May 2024 Date | | - Cons. EPS | - EPS |
Guerbet S.A. (GBT) FAQ
What is the stock price today?
The current price is €22.50.
On which exchange is it traded?
Guerbet S.A. is listed on XFRA.
What is its stock symbol?
The ticker symbol is GBT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.5%.
What is its market cap?
As of today, the market cap is 334.07M.
When is the next earnings date?
The next earnings report will release on Sep 24, 2025.
Has Guerbet S.A. ever had a stock split?
Guerbet S.A. had 1 splits and the recent split was on Jan 23, 2014.
Guerbet S.A. Profile
| Medical Devices Industry | Healthcare Sector | Mr. David Hale CEO | XPAR Exchange | FR0000032526 ISIN |
| France Country | 2,920 Employees | 1 Jul 2024 Last Dividend | 23 Jan 2014 Last Split | - IPO Date |
Overview
Guerbet SA is a pioneering company dedicated to the development and marketing of diagnostic and interventional imaging solutions worldwide. Established in 1926, the company has consistently been at the forefront of the imaging field, offering a wide range of contrast media products, delivery systems, medical devices, and related solutions. Headquartered in Villepinte, France, Guerbet SA is committed to advancing medical imaging technology to improve patient diagnosis and treatment, with a strong emphasis on innovation, particularly in the realms of MRI, CT, and Cath Lab consumables and digital solutions.
Products and Services
Guerbet SA's product lineup is diverse, covering different aspects of medical imaging and treatment. Here are some of their key offerings:
- Optiray and Xenetix: These are non-ionic, monomeric, and iodinated contrast agents used in various imaging procedures to improve clarity and detail.
- Telebrix Gastro: A meglumine ioxitalamate solution designed for gastrointestinal imaging.
- Conray: An iothalamate meglumine injection used for enhancing diagnostic images.
- Micropaque/Microtrast: A diagnostic imaging interconnected solution, which enhances the visualization of specific body parts during imaging procedures.
- Dotarem and Artirem: Gadoteric acid-based products acting as MRI contrast agents, facilitating clearer imaging of internal structures.
- Prefilled Syringes, Injectors, Accessories, and Consumables: For MRI, CT, and Cath Lab procedures, these products ensure efficient delivery of contrast media and seamless imaging processes.
- Digital Solutions:
- Contrast&Care: An injection management solution that optimizes the use and tracking of contrast media.
- Dose&Care: An X-ray dose management solution that helps control and reduce patients' exposure to radiation.
- icobrain: A cloud-based AI solution that supports the quantification of disease-specific brain structures on MR and CT scans, aiding in the diagnosis and treatment of acute and chronic neurological conditions.
- Interventional Radiology Products: Including Lipiodol, Vectorio, Patent Blue V, Axessio, and SeQure and DraKon microcatheters for targeted treatment and diagnostic procedures in interventional radiology.
- Hydra Vision: A digital imaging system designed for use in urological, gastroenterological, and gynecological treatments, as well as for planning and diagnostic procedures.
- Urology Accessories and Consumables: Specialized tools and products to support urological procedures and treatments.
Contact Information
Address: 15, rue des Vanesses
Phone: 33 1 45 91 50 00
Website: https://www.guerbet.com
2025 © Marketlog. All Rights Reserved.
